OLIVER LAGORE VANVALIN INVESTMENT GROUP Edwards Lifesciences Corporation Transaction History

OLIVER LAGORE VANVALIN INVESTMENT GROUP portfolio value:

$147,000
portfolio value

OLIVER LAGORE VANVALIN INVESTMENT GROUP quarter portfolio value change:

-13.10%
quarter

Edwards Lifesciences Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +1.02% 18 shares -21K $82.63 1.78K
Q2 2022 share Increase +3.76% 64 shares -32K $95.09 1.76K
Q1 2022 share Increase 0.00% 1.7K shares 200K $117.72 1.7K